Loading patent…
AssigneesAlkermes, Inc., The Regents of the University of California
InventorsPhillip M. Friden, Ruth M. Starzyk, Sherie L. Morrison, Eun-Chung Park, John P. McGrath
Estimating the term…
The present invention pertains to a method for delivering a neuropharmaceutical agent across the blood brain barrier to the brain of a host. The method comprises administering to the host a therapeutically effective amount of a ligand-neuropharmaceutical agent fusion protein wherein the ligand is reactive with a brain capillary endothelial cell receptor. Other aspects of this invention include a delivery system comprising a ligand reactive with a brain capillary endothelial cell receptor which has formed a fusion protein with a neuropharmaceutical agent. The fusion proteins are also aspects of this invention.
A fusion protein comprising a brain capillary endothelial cell receptor ligand and a neuropharmaceutical agent wherein:
A fusion protein comprising a brain capillary endothelial cell receptor ligand and a neuropharmaceutical agent wherein:
A fusion protein comprising a brain capillary endothelial cell receptor ligand and a neuropharmaceutical agent wherein:
A fusion protein comprising a brain capillary endothelial cell receptor ligand and a neuropharmaceutical agent wherein:
A fusion protein comprising a brain capillary endothelial cell receptor ligand and a neuropharmaceutical agent wherein:
Dependencies are inferred from the claim text.